Wells Fargo’s Telomir Pharmaceuticals TELO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$186 Sell
149
-10,122
-99% -$12.6K ﹤0.01% 5984
2025
Q1
$33.2K Buy
10,271
+227
+2% +$733 ﹤0.01% 5074
2024
Q4
$41.4K Buy
10,044
+8,245
+458% +$34K ﹤0.01% 5058
2024
Q3
$11.6K Buy
1,799
+9
+0.5% +$58 ﹤0.01% 5358
2024
Q2
$8.61K Buy
+1,790
New +$8.61K ﹤0.01% 5399